Zihni Onur UYGUN

Assoc. Prof. Dr. Zihni Onur UYGUN serves as an Associate Professor in the Department of Biochemistry at Ege University's Faculty of Medicine, Turkey. His research pioneers electrochemical biosensor technologies for advanced medical diagnostics, focusing on label-free detection systems integrating nanomaterials and molecular recognition elements.

His academic journey includes:

• PhD in Medical Biochemistry (Ege University, 2016-2020)
• PhD in Biotechnology (Kafkas University, 2025)
• Postdoctoral Research (Clarkson University, USA, 2023-2024)
• Postdoctoral Research (Koç University, Turkey, 2022-2023)
• MS in Medical Biochemistry (Ege University, 2014-2016)
• MS in Chemistry (Çanakkale Onsekiz Mart University, 2010-2012)
• BS in Biochemistry (Ege University, 2005-2010)

Dr. UYGUN's research focuses on nanobioelectrochemical systems for disease diagnostics, specializing in impedimetric biosensors, CRISPR-dCas9 technology, and molecularly imprinted polymers. His work targets cancer biomarkers (prostate, liver), infectious diseases (HIV), and inflammatory conditions (Crohn's disease) through non-invasive sampling methods.

His publication trend (2022-2025) reveals strategic evolution toward AI-integrated point-of-care diagnostics using MXenes, MOFs, and machine learning. Recent work emphasizes saliva/urine-based detection and mobile health integration, with significant contributions to CRISPR-based DNA sensing and environmental contaminant monitoring.

Scientific recognition includes:

• Leaders in Innovation Fellowship (2017)

He actively secures TÜBİTAK funding including the 2218 Post-Doctoral Research Grant and 2250 Graduate Scholarship Program. His projects span chemical detection technologies and medical biosensor development, with collaborations at Koç University and Clarkson University. Dr. UYGUN leads translational research in electrochemical diagnostics, evidenced by 29+ publications and an h-index of 16 (Google Scholar).

His laboratory specializes in impedimetric sensor fabrication and nanomaterial functionalization, currently developing systems for HIV detection, prostate cancer screening, and fertility assessment through paper-based colorimetric platforms.